SCHEMBL534933

SCHEMBL534933

CCCCC(=O)CC(=O)CCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 6/20 0.58
CES2 O00748 5/20 0.58
HAO1 Q9UJM8 1/20 0.56
ALDH1A1 P00352 4/20 0.52
TP53 P04637 1/20 0.52
KMT2A Q03164 2/20 0.50
MAPT P10636 1/20 0.50
CA1 P00915 1/20 0.50
AKR1B1 P15121 1/20 0.46
HSP90AA1 P07900 1/20 0.44
PPARG P37231 4/20 0.43
PPARD Q03181 4/20 0.43
PPARA Q07869 4/20 0.43
TSHR P16473 3/20 0.43
GPR84 Q9NQS5 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
TLR2 O60603 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30197707 0.97 CES1 (0.55) CES1CES2HAO1ALDH1A1TP53
Hydrochloric Acid SCHEMBL29053917 0.97 CES1 (0.55) CES1CES2HAO1ALDH1A1TP53
SCHEMBL30197621 0.97 CES1 (0.55) CES1CES2HAO1ALDH1A1TP53
SCHEMBL5917740 0.94 HAO1 (0.64) CES1CES2HAO1ALDH1A1KMT2A
SCHEMBL534886 0.94 CES1 (0.52) CES1CES2HAO1ALDH1A1TP53
SCHEMBL23361518 0.92 HAO1 (0.68) CES1CES2HAO1ALDH1A1KMT2A
SCHEMBL949144 0.92 CES1 (0.50) CES1CES2HAO1ALDH1A1TP53
SCHEMBL30943146 0.92 HAO1 (0.68) CES1CES2HAO1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL20399921 0.92 HAO1 (0.61) CES1CES2HAO1ALDH1A1KMT2A
SCHEMBL30690199 0.92 HAO1 (0.68) CES1CES2HAO1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110845987-A High-performance copolyamide hot melt adhesive composition 南通协鑫热熔胶有限公司 2020-02-28 CN claimed
US-9828324-B2 Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom SIRRUS, INC. (US) 2017-11-28 US claimed
US-20160068618-A1 METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM SIRRUS, INC. 2016-03-10 US claimed
US-20140275400-A1 METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM SIRRUS, INC. 2014-09-18 US claimed
EP-0912467-B1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE SA (FR) 2002-04-24 EP claimed
CN-119798279-A RAS inhibitors 锐新医药公司 2025-04-11 CN disclosed
CN-119462822-A RAS inhibitors 锐新医药公司 2025-02-18 CN disclosed
CN-119156393-A Cyclic compound, preparation method and medical application thereof 翰森生物有限责任公司 2024-12-17 CN disclosed
CN-118922423-A RAS inhibitors 锐新医药公司 2024-11-08 CN disclosed
CN-118679169-A RAS inhibitors 锐新医药公司 2024-09-20 CN disclosed
CN-118561952-A RAS inhibitors 锐新医药公司 2024-08-30 CN disclosed
CN-118234731-A RAS inhibitors 锐新医药公司 2024-06-21 CN disclosed
EP-0083690-A1 Polyamide acid composition for preparing polyimide and process for preparing polyimide from the same KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1983-07-20 EP disclosed
US-4208425-A VIRICIDES STERLING DRUG INC. (US) 1980-06-17 US disclosed
US-4171371-A Diketones STERLING DRUG INC. (US) 1979-10-16 US disclosed
US-4153719-A Aromatic diketones STERLING DRUG INC. (US) 1979-05-08 US disclosed
US-4096280-A Arylenedioxy-bis-diketones STERLING DRUG INC. (US) 1978-06-20 US disclosed
US-4093617-A ENZYME INHIBITORS ICN PHARMACEUTICALS, INC. (US) 1978-06-06 US disclosed
US-4051229-A REDUCTION OF ALKALI OR ALKALINE EARTH CHLORATE IN SULFURIC OR HYDROCHLORIC ACID WITH COMPLEX B-DIKETONE-PALLADIUM CATALYST THE JAPAN CARLIT CO., LTD. (JA) 1977-09-27 US disclosed
US-4036605-A CATALYZING OXIDATION OF HYDROCARBONS WITH A B-KETOENOLATE GULF RESEARCH & DEVELOPMENT COMPANY (US) 1977-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275400-A1 METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM BCKDK, ILK, PKM CES1 3934/4885CES2 3761/4885HAO1 1011/4885
US-20160068618-A1 METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM MSMO1, PKM, KHK CES1 3525/4885CES2 3526/4885HAO1 1071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.